Herr Amy E. 4

Accession 0001062993-25-002706

CIK 0000842023other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:49 PM ET

Size

24.8 KB

Accession

0001062993-25-002706

Form 4

Period: 2025-02-14

Director

Transactions

Exercise/Conversion
Common Stock
2025-02-14$44.33/sh+1,976$87,596→ 3,836 total(indirect: By significant other)
Sale
Common Stock
2025-02-14$65.96/sh−1,860$122,691→ 1,976 total(indirect: By significant other)
Exercise/Conversion
Stock Option (Right to Buy)
2025-02-14−1,976→ 1,280 total(indirect: By significant other)
Exercise: $44.33Exp: 2025-08-08→ Common Stock (3,256 underlying)

Holdings

Common Stock
1,040
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (115 underlying)
115
Stock Option (Right to Buy)
Exercise: $72.05Exp: 2035-02-03→ Common Stock (2,415 underlying)
2,415
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (6,636 underlying)
6,636
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (4,472 underlying)
4,472
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (2,076 underlying)
2,076
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (2,104 underlying)
2,104
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (1,084 underlying)
1,084
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $74.91Exp: 2034-08-15→ Common Stock (1,468 underlying)
1,468
Stock Option (Right to Buy)
(indirect: By significant other)
Exercise: $72.05Exp: 2025-02-03→ Common Stock (344 underlying)
344
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (237 underlying)
237
Restricted Stock Units
(indirect: By significant other)
→ Common Stock (480 underlying)
480

Footnotes (11)

[F1]The option vests on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's annual meeting of shareholders.
[F10]160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
[F11]38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
[F2]Fully vested.
[F3]520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and 516 shares vest on 8/6/2024.
[F4]528 shares vest on 8/15/2023 and 8/15/2025; 524 shares vest on 8/15/2024 and 8/15/2026.
[F5]271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
[F6]367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F7]86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
[F8]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F9]119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother